These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15515310)

  • 41. Antimicrobial resistance: insights into control and treatment of complicated infections. Introduction.
    Rapp RP
    Pharmacotherapy; 2005 Oct; 25(10 Pt 2):41S-43S. PubMed ID: 16178674
    [No Abstract]   [Full Text] [Related]  

  • 42. Severe acute exacerbation of chronic obstructive pulmonary disease: when are multiple-drug-resistant bacteria the culprits?
    Epstein SK
    Crit Care Med; 2006 Dec; 34(12):3047-8. PubMed ID: 17130702
    [No Abstract]   [Full Text] [Related]  

  • 43. Letter in response to the Infectious Diseases Society of America's 10 x '20 Initiative.
    Burgess DS; Slain D; Mohr J; Wong-Beringer A; Destache C; Suda K
    Clin Infect Dis; 2010 Sep; 51(6):753; author reply 754-5. PubMed ID: 20731568
    [No Abstract]   [Full Text] [Related]  

  • 44. Selection of antibiotic-resistant pathogens in the community.
    Yagupsky P
    Pediatr Infect Dis J; 2006 Oct; 25(10):974-6. PubMed ID: 17006309
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pursuing appropriateness of antimicrobial therapy prescription: is Italy on the move at last?
    Pagani L; Aschbacher R
    Am J Infect Control; 2009 Oct; 37(8):692-4. PubMed ID: 19782252
    [No Abstract]   [Full Text] [Related]  

  • 46. Strengthening surveillance key to addressing antimicrobial resistance.
    Walia K; Ohri VC
    Indian J Med Microbiol; 2016; 34(4):413-415. PubMed ID: 27934816
    [No Abstract]   [Full Text] [Related]  

  • 47. Use of molecular typing in infection control.
    Patel SJ; Graham PL
    Pediatr Infect Dis J; 2007 Jun; 26(6):527-9. PubMed ID: 17529871
    [No Abstract]   [Full Text] [Related]  

  • 48. [Surveillance of antibiotic use and resistance].
    Meyer E; Gastmeier P
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Feb; 42(2):116-20. PubMed ID: 17309019
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antimicrobial stewardship stabilizes resistance patterns in a behavioral health setting.
    Freedman K; Kolluri B; Neudecker L
    Conn Med; 2007 Sep; 71(8):457-60. PubMed ID: 17902382
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibiotic use in neonatal intensive care.
    Soll RF; Edwards WH
    Pediatrics; 2015 May; 135(5):928-9. PubMed ID: 25896842
    [No Abstract]   [Full Text] [Related]  

  • 51. [Management of multiresistant bacteria].
    Ramé A
    Rev Infirm; 2006 May; (121):32-3. PubMed ID: 16792047
    [No Abstract]   [Full Text] [Related]  

  • 52. Clostridium difficile-associated diarrhoea rates and global antibiotic consumption in five Quebec institutions from 2001 to 2004.
    Weiss K; Bergeron L; Bernatchez H; Goyette M; Savoie M; Thirion D
    Int J Antimicrob Agents; 2007 Oct; 30(4):309-14. PubMed ID: 17644347
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multi-targeting by monotherapeutic antibacterials.
    Silver LL
    Nat Rev Drug Discov; 2007 Jan; 6(1):41-55. PubMed ID: 17159922
    [TBL] [Abstract][Full Text] [Related]  

  • 54. National progress on antimicrobial resistance.
    The Lancet
    Lancet; 2017 May; 389(10084):2082. PubMed ID: 28560991
    [No Abstract]   [Full Text] [Related]  

  • 55. Trends in antimicrobial resistance in Europe: update of EARSS results.
    de Kraker M; van de Sande-Bruinsma N
    Euro Surveill; 2007 Mar; 12(3):E070315.3. PubMed ID: 17439787
    [No Abstract]   [Full Text] [Related]  

  • 56. The effect of limiting antimicrobial therapy duration on antimicrobial resistance in the critical care setting.
    Marra AR; de Almeida SM; Correa L; Silva M; Martino MD; Silva CV; Cal RG; Edmond MB; dos Santos OF
    Am J Infect Control; 2009 Apr; 37(3):204-9. PubMed ID: 18986735
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prudent use of antibacterial agents: are we entering in an era of infections with no effective antibacterial agents? What can we do?
    Vila J; Rodríguez-Baño J; Gargallo-Viola D
    Enferm Infecc Microbiol Clin; 2010 Nov; 28(9):577-9. PubMed ID: 21029869
    [No Abstract]   [Full Text] [Related]  

  • 58. The need for new antibiotics.
    Livermore DM
    Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():1-9. PubMed ID: 15522034
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Severe infections: source control and antimicrobial therapy].
    Dupont H
    Ann Fr Anesth Reanim; 2006 Mar; 25(3):263-9. PubMed ID: 16387469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Antibiotic therapy: progress and development of resistance].
    Adam D
    Internist (Berl); 2006 Jul; 47(7):758-63. PubMed ID: 16703381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.